Immunotherapy for antineutrophil cytoplasmic antibody–associated vasculitis: challenging the therapeutic status quo?
- 30 June 2008
- journal article
- review article
- Published by Elsevier in Trends in Immunology
- Vol. 29 (6) , 280-289
- https://doi.org/10.1016/j.it.2008.03.001
Abstract
No abstract availableKeywords
This publication has 86 references indexed in Scilit:
- Treatment of Antineutrophil Cytoplasmic Antibody–Associated VasculitisJAMA, 2007
- Churg–Strauss syndromeCurrent Opinion in Rheumatology, 2007
- Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitidesNature Clinical Practice Rheumatology, 2006
- Antineutrophil cytoplasmic antibodiesThe Lancet, 2006
- Advances in the therapy of Wegener's granulomatosisCurrent Opinion in Rheumatology, 2006
- The antineutrophil cytoplasmic antibody–associated vasculitidesThe American Journal of Medicine, 2004
- Prospective Study of TNFα Blockade with Infliximab in Anti-Neutrophil Cytoplasmic Antibody-Associated Systemic VasculitisJournal of the American Society of Nephrology, 2004
- Treatment of ANCA-Associated VasculitisNew England Journal of Medicine, 2003
- Small-Vessel VasculitisNew England Journal of Medicine, 1997
- Nomenclature of Systemic VasculitidesArthritis & Rheumatism, 1994